Remove Doctors Remove Genetics Remove Medicine Remove Pharma Companies
article thumbnail

Sohonos (Palovarotene) Sets Milestone as First Drug for Ultra-Rare Bone Disease

XTalks

“For the first time, doctors have an approved medicine available to them, shown to reduce the formation of new, abnormal bone growth, known as heterotopic ossification (HO), which causes debilitating mobility challenges and has a devastating impact on the lives of people with FOP.”

Drugs 98
article thumbnail

Katie Porter attacks pharma

World of DTC Marketing

The venture capitalists funding them are looking for a big payday when a pharma company acquires them. I have been recruited by these companies who promise huge payouts when they are acquired if their drug shows promise in clinical trials. In pharma R&D returns have declined to 1.8 percent—a slight decrease of 0.1

In-Vivo 187
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Moderna and BioNTech – who are they?

pharmaphorum

Compared with many of the established names in pharma these companies are young upstarts but they have managed to achieve what other big names in the industry have failed to do and harness the power of mRNA to make medicine. They are very good doctors, scientists and entrepreneurs. appeared first on.

article thumbnail

Pfizer drops the blue pill, kicks off 2021 with new DNA logo

pharmaphorum

Pharma companies are always talking about moving ‘beyond the pill’, and Pfizer’s new brand identity embodies that – it’s decades old pill-like logo has been replaced with a DNA double helix that it says reflects its commitment to breakthrough science.

DNA 116
article thumbnail

5 Top Emerging Pharmacovigilance Startups Impacting The Industry

Cloudbyz

Time is also of the essence in drug development, as competitive product-to-market lead times help pharma companies improve profitability. With the help of artificial intelligence (AI) and individual genetic data, the software predicts the potential effects drugs have on specific genetic markers.

article thumbnail

WHO Honors the Legacy and Contribution of Henrietta Lacks

XTalks

The lawsuit claims that Thermo Fisher is profiting off the stolen tissue samples, despite the broad publicity that Lacks’ story has received over the past decade and its link to a long tradition of discriminatory practices in medicine. Lacks and her family has been exposed to the general public.”.

article thumbnail

Gene editing: beyond the hype

pharmaphorum

‘Cutting edge’ is, for once, a truly apt description when it comes to gene editing – both because the field is pushing medicine into areas we might never have dreamed possible, and because these technologies involve literally cutting DNA at a specific point in the genome. The genomic medicine journey.